At a glance
| Japanese name | 大塚製薬株式会社 |
|---|---|
| Established | 1921 |
| Location | Chiyoda (HQ), Tokyo |
| Factory locations | Naruto, Tokushima (major factory) |
| English support | Available |
| Export experience | Global |
| Certifications | GMP |
| Website | www.otsuka.co.jp/en |
About
Global pharmaceutical company. Discovered the world's first food-grade Equol-producing lactic acid bacterium 'Lactococcus 20-92' after 18+ years of research and screening 1,300+ strains. Launched 'Equelle' (EQUELLE) in 2014 as the world's first commercial fermented-soy Equol supplement. 'Yuragi-ki®' (ゆらぎ期®) is Otsuka's registered trademark for menopause-era marketing. Product line: Equelle tablets (10mg Equol/4-tablet daily), Equelle Petit (compact 2-tablet daily), Equelle Jelly (orange-flavored with vitamin D, collagen, calcium).
Ingredients offered
Disclaimer
Japan Ingredient Sourcing Platform introduces overseas buyers to Japanese ingredient manufacturers. The platform is an information service only and is not a party to any purchase, supply, or manufacturing contract between buyer and seller.
Information shown — including company details, product descriptions, regions of origin, minimum order quantities, lead times, certifications, and regulatory references — is compiled primarily from publicly available sources and manufacturer websites. Specifications change without notice; buyers are expected to verify current specifications, pricing, certification status, and regulatory compliance directly with each manufacturer before placing orders or signing contracts.
The platform operator is not licensed to provide legal, regulatory, customs, tax, or professional advice. References to third-party companies, products, certifications, trademarks, and geographical indications (GI) are factual and do not imply endorsement, sponsorship, or affiliation. All trademarks are the property of their respective owners.
Last updated: 2026-04-24